Skip to main content

Latest stock market podcasts

Part 2 Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 10 March

Sophia Mavridis
March 10, 2022

Morning Bell 9 March

Paulina Peters
March 9, 2022

Morning Bell 8 March

Sophia Mavridis
March 8, 2022

Morning Bell 7 March

Sophia Mavridis
March 7, 2022

Weekly Wrap 4 March

Sophia Mavridis
March 4, 2022

Morning Bell 3 March

Sophia Mavridis
March 3, 2022

Morning Bell 2 March

Sophia Mavridis
March 2, 2022

Morning Bell 1 March

Sophia Mavridis
March 1, 2022

Morning Bell 28 February

Sophia Mavridis
February 28, 2022

Weekly Wrap 25 February

Sophia Mavridis
February 25, 2022

Morning Bell 24 February

Paulina Peters
February 24, 2022

Morning Bell 23 February

Sophia Mavridis
February 23, 2022